Search Results - "Baker, Owen R"

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors by Benner, Sarah E, Patel, Eshan U, Laeyendecker, Oliver, Pekosz, Andrew, Littlefield, Kirsten, Eby, Yolanda, Fernandez, Reinaldo E, Miller, Jernelle, Kirby, Charles S, Keruly, Morgan, Klock, Ethan, Baker, Owen R, Schmidt, Haley A, Shrestha, Ruchee, Burgess, Imani, Bonny, Tania S, Clarke, William, Caturegli, Patrizio, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C, Bloch, Evan M, Casadevall, Arturo, Tobian, Aaron A R, Redd, Andrew D

“…Abstract Background Convalescent plasma therapy is a leading treatment for conferring temporary immunity to COVID-19–susceptible individuals or for use as…”
Get full text

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals by Saraf, Sharada, Zhu, Xianming, Shrestha, Ruchee, Bonny, Tania S, Baker, Owen R, Beck, Evan J, Fernandez, Reinaldo E, Eby, Yolanda, Akinde, Olivia, Ruff, Jessica E, Caturegli, Patrizio, Redd, Andrew D, Bloch, Evan M, Quinn, Thomas C, Tobian, Aaron A R, Laeyendecker, Oliver

“…The association between COVID-19 symptoms and antibody responses against SARS-CoV-2 is poorly characterized. We analyzed antibody levels in individuals with…”
Get full text

The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States by Smith, Claire P, Hartman, Rachel M, Kugler, Alexa M, Little, Verlena, Baker, Owen R, Fairlie, Tarayn A, Fernandez, Reinaldo E, Hagen, Melissa B, Honie, Elvira, Laeyendecker, Oliver, Midgley, Claire M, Parker, Dennie, Sandoval, Marqia, Takahashi, Saki, Hammitt, Laura L, Sutcliffe, Catherine G

“…SARS-CoV-2 antibody kinetics based on immunologic history is not fully understood. We analyzed anti-spike and anti-nucleocapsid antibody responses following…”
Get full text

Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland by Patel, Eshan U., Mehta, Shruti H., Genberg, Becky L., Baker, Owen R., Schluth, Catherine G., Astemborski, Jacquie, Fernandez, Reinaldo E., Quinn, Thomas C., Kirk, Gregory D., Laeyendecker, Oliver

“…•Prevalence of infection-induced SARS-CoV-2 antibodies was 26%.•Prevalence of infection and/or vaccination-induced SARS-CoV-2 antibodies was 63%.•The…”
Get full text

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers by Patel, Eshan U, Bloch, Evan M, Clarke, William, Hsieh, Yu-Hsiang, Boon, Denali, Eby, Yolanda, Fernandez, Reinaldo E, Baker, Owen R, Keruly, Morgan, Kirby, Charles S, Klock, Ethan, Littlefield, Kirsten, Miller, Jernelle, Schmidt, Haley A, Sullivan, Philip, Piwowar-Manning, Estelle, Shrestha, Ruchee, Redd, Andrew D, Rothman, Richard E, Sullivan, David, Shoham, Shmuel, Casadevall, Arturo, Quinn, Thomas C, Pekosz, Andrew, Tobian, Aaron A R, Laeyendecker, Oliver

“…Accurate serological assays to detect antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of…”
Get full text

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing by Conklin, Steven E, Martin, Kathryn, Manabe, Yukari C, Schmidt, Haley A, Miller, Jernelle, Keruly, Morgan, Klock, Ethan, Kirby, Charles S, Baker, Owen R, Fernandez, Reinaldo E, Eby, Yolanda J, Hardick, Justin, Shaw-Saliba, Kathryn, Rothman, Richard E, Caturegli, Patrizio P, Redd, Andrew D, Tobian, Aaron A R, Bloch, Evan M, Larman, H Benjamin, Quinn, Thomas C, Clarke, William, Laeyendecker, Oliver

“…Rapid point-of-care tests (POCTs) for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies vary in performance. A…”
Get full text

Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples by Baker, Owen R, Grabowski, M Kate, Galiwango, Ronald M, Nalumansi, Aminah, Serwanga, Jennifer, Clarke, William, Hsieh, Yu-Hsiang, Rothman, Richard E, Fernandez, Reinaldo E, Serwadda, David, Kagaayi, Joseph, Lutalo, Tom, Reynolds, Steven J, Kaleebu, Pontiano, Quinn, Thomas C, Laeyendecker, Oliver

“…We assessed the performance of the CoronaCHEK lateral flow assay on samples from Uganda and Baltimore to determine the impact of geographic origin on assay…”
Get full text

High Burden of Undiagnosed Hepatitis B and Liver Disease in an Urban Emergency Department—Baltimore, 2020 by Wang, Richard, Rothman, Richard E., Mohareb, Amir M., Laeyendecker, Oliver, Cloherty, Gavin A., Quinn, Thomas C., Hsieh, Yu-Hsiang, Anderson, Mark, Solomon, Sunil S., Fernandez, Reinaldo E., Dashler, Gaby, Mehta, Radhika, Stec, Michael, Kickler, Thomas, Kelen, Gabor D., Mehta, Shruti H., Beck, Evan J., Saraf, Sharada, Baker, Owen R., Lake, Isabel V., Ricketts, Erin P., Anderson, Danna, Hurley, Jennifer

Get full text

Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department by Laeyendecker, Oliver, Hsieh, Yu-Hsiang, Rothman, Richard E., Dashler, Gaby, Kickler, Thomas, Fernandez, Reinaldo E., Clarke, William, Patel, Eshan U., Tobian, Aaron A.R., Kelen, Gabor D., Quinn, Thomas C., Schmidt, Haley A., Miller, Jernelle, Keruly, Morgan, Klock, Ethan, Kirby, Charles S., Baker, Owen R., Wang, Richard, Lake, Isabel V., Youbi, Mehdi, Reineck, Sarah, Khan, Momina, Knaub, Ross, Ricketts, Erin, Eby, Yolanda J., Anderson, Danna, Hurley, Jennifer

“…Emergency Departments (EDs) have served as critical surveillance sites for infectious diseases. We sought to determine the prevalence and temporal trends of…”
Get full text

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study by Zhu, Xianming, Gebo, Kelly A, Abraham, Alison G, Habtehyimer, Feben, Patel, Eshan U, Laeyendecker, Oliver, Gniadek, Thomas J, Fernandez, Reinaldo E, Baker, Owen R, Ram, Malathi, Cachay, Edward R, Currier, Judith S, Fukuta, Yuriko, Gerber, Jonathan M, Heath, Sonya L, Meisenberg, Barry, Huaman, Moises A, Levine, Adam C, Shenoy, Aarthi, Anjan, Shweta, Blair, Janis E, Cruser, Daniel, Forthal, Donald N, Hammitt, Laura L, Kassaye, Seble, Mosnaim, Giselle S, Patel, Bela, Paxton, James H, Raval, Jay S, Sutcliffe, Catherine G, Abinante, Matthew, Broderick, Patrick, Cluzet, Valerie, Cordisco, Marie Elena, Greenblatt, Benjamin, Petrini, Joann, Rausch, William, Shade, David, Lane, Karen, Gawad, Amy L, Klein, Sabra L, Pekosz, Andrew, Shoham, Shmuel, Casadevall, Arturo, Bloch, Evan M, Hanley, Daniel, Sullivan, David J, Tobian, Aaron A R

“…Cytokines and chemokines play a critical role in the response to infection and vaccination. We aimed to assess the longitudinal association of COVID-19…”
Get full text

Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen by Ferreira, Roux-Cil, Reynolds, Steven J., Capoferri, Adam A., Baker, Owen R., Brown, Erin E., Klock, Ethan, Miller, Jernelle, Lai, Jun, Saraf, Sharada, Kirby, Charles, Lynch, Briana, Hackman, Jada, Gowanlock, Sarah N., Tomusange, Stephen, Jamiru, Samiri, Anok, Aggrey, Kityamuweesi, Taddeo, Buule, Paul, Bruno, Daniel, Martens, Craig, Rose, Rebecca, Lamers, Susanna L., Galiwango, Ronald M., Poon, Art F.Y., Quinn, Thomas C., Prodger, Jessica L., Redd, Andrew D.

“…The principal barrier to an HIV cure is the presence of the latent viral reservoir (LVR), which has been understudied in African populations. From 2018 to…”
Get full text

A Tale of 3 Pandemics: Severe Acute Respiratory Syndrome Coronavirus 2, Hepatitis C Virus, and Human Immunodeficiency Virus in an Urban Emergency Department in Baltimore, Maryland by Hsieh, Yu-Hsiang, Rothman, Richard E, Solomon, Sunil S, Anderson, Mark, Stec, Michael, Laeyendecker, Oliver, Lake, Isabel V, Fernandez, Reinaldo E, Dashler, Gaby, Mehta, Radhika, Kickler, Thomas, Kelen, Gabor D, Mehta, Shruti H, Cloherty, Gavin A, Quinn, Thomas C

“…Abstract Background We sought to determine the prevalence and sociodemographic and clinical correlates of acute and convalescent severe acute respiratory…”
Get full text

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Status in Decedents Undergoing Forensic Postmortem Examination in Maryland, May 24 to June 30, 2020 by Althoff, Keri N, Laeyendecker, Oliver, Li, Rong, Coburn, Sally B, Klock, Ethan, Baker, Owen R, Quinn, Thomas C, Michael, Jeffrey, Shields, Wendy C, Ehsani, Johnathon, Thomas, F Dennis, Graham, Lindsey A, Ali, Zabiullah, Manabe, Yukari C, Li, Ling

“…Abstract Seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies was 10% among the subset of decedents undergoing forensic…”
Get full text

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for 
Real-Time Pandemic Surveillance by Coburn, Sally B, Manabe, Yukari C, Laeyendecker, Oliver, Sherman, Susan G, Baker, Owen R, Quinn, Thomas C, Graham, Lindsey A, Dennis Thomas, F, Southall, Pamela, Weedn, Victor W, Ehsani, Johnathon, Klock, Ethan, Li, Rong, Shields, Wendy C, Michael, Jeffrey Paul, Li, Ling, Althoff, Keri N

“…Abstract Background Population-based seroprevalence studies offer comprehensive characterization of coronavirus disease 2019 (COVID-19) spread, but barriers…”
Get full text

Early antibody treatment, inflammation, and risk of post-COVID conditions by Gebo, Kelly A, Heath, Sonya L, Fukuta, Yuriko, Zhu, Xianming, Baksh, Sheriza, Abraham, Allison G, Habtehyimer, Feben, Shade, David, Ruff, Jessica, Ram, Malathi, Laeyendecker, Oliver, Fernandez, Reinaldo E, Patel, Eshan U, Baker, Owen R, Shoham, Shmuel, Cachay, Edward R, Currier, Judith S, Gerber, Jonathan M, Meisenberg, Barry, Forthal, Donald N, Hammitt, Laura L, Huaman, Moises A, Levine, Adam, Mosnaim, Giselle S, Patel, Bela, Paxton, James H, Raval, Jay S, Sutcliffe, Catherine G, Anjan, Shweta, Gniadek, Thomas, Kassaye, Seble, Blair, Janis E, Lane, Karen, McBee, Nichol A, Gawad, Amy L, Das, Piyali, Klein, Sabra L, Pekosz, Andrew, Bloch, Evan M, Hanley, Daniel, Casadevall, Arturo, Tobian, Aaron A R, Sullivan, David J

“…Approximately 20% of individuals infected with SARS-CoV-2 experienced long-term health effects, as defined PCC. However, it is unknown if there are any early…”
Get full text

Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions" by Gebo, Kelly A, Heath, Sonya L, Fukuta, Yuriko, Zhu, Xianming, Baksh, Sheriza, Abraham, Allison G, Habtehyimer, Feben, Shade, David, Ruff, Jessica, Ram, Malathi, Laeyendecker, Oliver, Fernandez, Reinaldo E, Patel, Eshan U, Baker, Owen R, Shoham, Shmuel, Cachay, Edward R, Currier, Judith S, Gerber, Jonathan M, Meisenberg, Barry, Forthal, Donald N, Hammitt, Laura L, Huaman, Moises A, Levine, Adam, Mosnaim, Giselle S, Patel, Bela, Paxton, James H, Raval, Jay S, Sutcliffe, Catherine G, Anjan, Shweta, Gniadek, Thomas, Kassaye, Seble, Blair, Janis E, Lane, Karen, McBee, Nichol A, Gawad, Amy L, Das, Piyali, Klein, Sabra L, Pekosz, Andrew, Bloch, Evan M, Hanley, Daniel, Casadevall, Arturo, Tobian, Aaron A R, Sullivan, David J

Get full text

Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenResearch in context by Roux-Cil Ferreira, Steven J. Reynolds, Adam A. Capoferri, Owen R. Baker, Erin E. Brown, Ethan Klock, Jernelle Miller, Jun Lai, Sharada Saraf, Charles Kirby, Briana Lynch, Jada Hackman, Sarah N. Gowanlock, Stephen Tomusange, Samiri Jamiru, Aggrey Anok, Taddeo Kityamuweesi, Paul Buule, Daniel Bruno, Craig Martens, Rebecca Rose, Susanna L. Lamers, Ronald M. Galiwango, Art F.Y. Poon, Thomas C. Quinn, Jessica L. Prodger, Andrew D. Redd

“…Background: The principal barrier to an HIV cure is the presence of the latent viral reservoir (LVR), which has been understudied in African populations. From…”
Get full text

401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy by Fukuta, Yuriko, Gebo, Kelly, Heath, Sonya L, Zhu, Xianming, Baksh, Sheriza, Abraham, Alison G, Habtehyimer, Feben, Shade, David, Ruff, Jessica E, Ram, Malathi, Laeyendecker, Oliver, Fernandez, Reinaldo, Patel, Eshan U, Baker, Owen R, Shoham, Shmuel, Cachay, Edward R, Currier, Judith S, Gerber, Jonathan, Meisenberg, Barry, Hammitt, Laura, Forthal, Donald, Huaman, Moises A, Levine, Adam C, Mosnaim, Giselle, Patel, Bela, Paxton, James, Raval, Jay S, Sutcliffe, Catherine, Anjan, Shweta, Gniadek, Thomas, Kassaye, Seble, Blair, Janis E, Lane, Karen, McBee, Nichol, Gawad, Amy, Das, Piyali, Klein, Sabra L, Pekosz, Andrew, Bloch, Evan, Hanley, Daniel, Casadevall, Arturo, Tobian, Aaron, Sullivan, David

“…Abstract Background Post-COVID conditions (PCC) are common, and risk factors include older age and female sex. While high interleukin (IL)-6 and C-reactive…”
Get full text

COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial by Habtehyimer, Feben, Zhu, Xianming, Redd, Andrew D, Gebo, Kelly A, Abraham, Alison G, Patel, Eshan U, Laeyendecker, Oliver, Gniadek, Thomas J, Fernandez, Reinaldo E, Baker, Owen R, Ram, Malathi, Cachay, Edward R, Currier, Judith S, Fukuta, Yuriko, Gerber, Jonathan M, Heath, Sonya L, Meisenberg, Barry, Huaman, Moises A, Levine, Adam C, Shenoy, Aarthi, Anjan, Shweta, Blair, Janis E, Cruser, Daniel, Forthal, Donald N, Hammitt, Laura L, Kassaye, Seble, Mosnaim, Giselle S, Patel, Bela, Paxton, James H, Raval, Jay S, Sutcliffe, Catherine G, Abinante, Matthew, Oei, Kevin S, Cluzet, Valerie, Cordisco, Marie Elena, Greenblatt, Benjamin, Rausch, William, Shade, David, Gawad, Amy L, Klein, Sabra L, Pekosz, Andrew, Shoham, Shmuel, Casadevall, Arturo, Bloch, Evan M, Hanley, Daniel, Tobian, Aaron A R, Sullivan, David J

“…This study examined the role that cytokines may have played in the beneficial outcomes found when outpatient individuals infected with SARS-CoV-2 were…”
Get full text